Article PDF
References
Cohen, J. Science 258, 536–539 (1992).
Culliton, J. Nature 360, 13 (1992).
Moore, J. P. et al. AIDS 4, 307–315 (1990).
Steimer, K. S. et al. Science 254, 105–108 (1992).
Chamat, S. et al. J. Immun. 149, 649–654 (1992).
Moore, J. P. & Ho, D. D. J. Virol. 67, 863–875 (1993).
LaRosa, G. J. et al. Science 249, 932–935 (1990).
Warren, R. Q. et al. AIDS (submitted).
Klinman, D. M., Steimer, K. S. & Conover, J. J. AIDS 5, 1005–1008 (1992).
Haigwood, N. L. et al. J. Virol. 66, 172–182 (1992).
Brown, P. New Scient. 8 (24 October 1992).
Cohen, J. Science 258, 883–884 (1992).
Berman, P. W. et al. J. Virol. 66, 4464–4469 (1992).
Siliciano, R. F. et al. J. Immun. 142, 1506–1511 (1989).
Redfield, R. R. & Birx, D. L. AIDS Res. hum. Retrovir. 8, 1051–1058 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, J., Lewis, G. & Robinson, J. Which gplGO vaccine?. Nature 361, 503 (1993). https://doi.org/10.1038/361503a0
Issue Date:
DOI: https://doi.org/10.1038/361503a0
This article is cited by
-
Properties of an HIV 'Vaccine'
Nature (1993)
-
Properties of an HIV 'Vaccine'
Nature (1993)
-
Properties of an HIV 'Vaccine'
Nature (1993)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.